What question did this study set out to answer?

To examine how women receiving adjuvant chemotherapy for node-positive breast cancer interpret disease risk, manage information needs, and cope with treatment demands.

February 1, 2000Journal of Advanced Nursing

How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective

View Full Paper

Ask AI

Bookmark

Authors

LCLorraine CowleyNewcastle upon Tyne Hospitals NHS Foundation Trust BHBob HeymanUniversity of Huddersfield MSMichelle C. StantonLiverpool School of Tropical Medicine

Discussion

Member takes

Implication

Qualitative study uncovers contrasting risk perceptions and coping strategies in women receiving adjuvant breast cancer chemotherapy, highlighting a critical risk communication dilemma.

Key Points

To examine how women receiving adjuvant chemotherapy for node-positive breast cancer interpret disease risk, manage information needs, and cope with treatment demands.
Conducted retrospective, nonstandardized qualitative interviews with 12 women (N=12) one year after an 18-week course of adjuvant chemotherapy for node-positive breast cancer without disease recurrence.
Analyzed interview data through theoretical frameworks of patient career, trajectory projection, and qualitative risk analysis.
Women held sharply contrasting preconceptions of treatment, ranging from viewing it lightly as an 'insurance policy' due to minimized risk discussions to equating it with curative care with imminent mortality.
Participants relied on normalizing strategies such as maintaining routines, finding humor, and keeping a brave face, but cyclical side effects created an unpredictable rollercoaster that impeded emotional stability.

Cite This Study

Cowley et al. (2000) studied this question.

synapsesocial.com/papers/6a6fe0bca7fbea1e4407df49 https://doi.org/10.1046/j.1365-2648.2000.01295.x

View Full Paper

Ask AI

Bookmark

Implication

Qualitative study uncovers contrasting risk perceptions and coping strategies in women receiving adjuvant breast cancer chemotherapy, highlighting a critical risk communication dilemma.

How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective

Discussion

Member takes

Implication

Key Points

Cite This Study

How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider